Pain Medicine and Management

Psychologist and Environmental Consultant. He completed doctoral studies in the Department of Personality, Evaluation and Psychological Treatment of the UNED. Chief of Brigade in a Forest Fire Service with more than 20 years of experience. He collaborates with several companies and institutions in the area of training in Psychology in Emergencies and Human Resources. He is Professor at the University of Valencia in the Master in "Intervention and operational coordination in emergencies and catastrophes" and other postgraduate courses on emergencies. Director and President of the International Scientific-Professional Committee of the National Symposium on Forest Fires (SINIF). He has lectured internationally and has been part of the Organizing Committee of several International Congresses on Earth Sciences and Climate Change. He has published articles on forest fires, stress, psychosocial risks and emotional trauma, mainly in relation to emergency services and natural disasters. Currently, he is assigned to the Research Group on "Climate and Territorial Planning" (University of Alicante), where he researches on the social perception of forest fire risk and behavior in the event of possible disasters.

Climate and Territorial Planning, Regional Geography and Physical Geography,Social Perception of Forest Fire Risk

Yon Rojanasakul, Ph.D., is a Professor in the Department of Pharmaceutical Sciences at West Virginia University. Dr. Rojanasakul’s research focuses on understanding the cellular and molecular mechanisms of cancer and fibroproliferative disorders. His research has led to the discovery of key molecular targets and signaling pathways involved in cancer cell death and chemoresistance. The overall goal of his research is to develop more effective strategies for the treatment and diagnosis of cancer and fibrosis. Another key area of Rojanasakul’s research involves nanotechnology with an emphasis on the long-term health effects of engineered nanoparticles. His research develops exposure models and assay methods for nanosafety evaluation, identifies key properties of nanomaterials influencing their bioactivities, and elucidates the cellular and molecular mechanisms of pathogenesis. Dr. Rojanasakul is Principal Investigator of several projects funded by the National Institutes of Health and the National Science Foundation. He is Robert C. Byrd Professor and Benedum Distinguished Scholar at the West Virginia University. He is also a Fellow of the American Association of Pharmaceutical Scientists and Program Leader of the WVU Cancer Center.

Carcinogenesis and Cancer Treatment Nanosafety and Nanomedicine Free Radical Biology Molecular Pharmacology

Dr Abbas Amini is an associate lecturer, a registered member of Western Sydney University graduate supervisory board at the School of Computing, Engineering and Mathematics, and the member of Work Health and Safety Committee of the same university. Before joining the Western Sydney University, he had conducted research with other Australian universities and CSIRO for a period of five years, at Monash University, Deakin University, and the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group. Abbas started his teaching, industrial and scientific journey from obtaining an associate’s degree in mathematics, BSc and MSc in mechanical engineering, and PhD in both nanotechnology and mechanical engineering from the Hong Kong University of Science and Technology. He has also updated himself by several Australian and Canadian nationally recognized professional certificates and diplomas, e.g., FULT (Foundations of University Learning and Teaching from Western Sydney University), TAE, WHS, CNC etc., since then. With his intense schedule, he has been extensively involved in teaching for many years, and worked in industry, e.g., Magna Powertrain, Toronto, Canada, as a professional engineer and industrial designer for a period of six years. Dr Amini is a member of American Society of Mechanical Engineers (ASME), an active reviewer for and editor of several ISI journals, and a committee member of 14 international conferences to-date, including the co-chair of 8th International Conference of ICCAE 2016, Melbourne, Australia, Mar. 3-4, 2016. Dr Amini is supervising four PhD candidates at present, and is open for scientific and funding collaborations.

Dr Amini's research focus in particular covers a wide range of multidisciplinary aspects: biomedical materials, bioplastics, shape memory alloys, water treatment, drug delivery systems, piezoelectric materials, graphene, graphane, CNTs, biodegradable polymeric nano-composites, TiO2, ZnO, environmental sustainability and water efficiency, experimental analysis, multi-scale (nano to macro) modelling of multi-physics phenomena, indentation methods, 3D printing, phase transition, mechanics of materials, fabrication of modern composites, manufacturing, offshore naval structures, and ship design. Key words: Bionanotechnology; Biodegradabple polymers; 3D printing; Biomedical materails; Shape memory alloys; Bio-applications of carbon-base materials

Dr Sergey Suchkov, MD, PhD. Professor in Immunology & Medicine. Director, Center for Personalized Medicine, Sechenov University and Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI). Born on 11 Jan 1957, Astrakhan, Russia; two sons. Education: MD, Astrakhan State Medical University, Russia, 1980; PhD, I.M.Sechenov First Moscow State Medical University, 1985; Doctor Degree, National Institute of Immunology, Russia, 2001. Positions held: Post Doc Research Associate, Institute of Medical Enzymology; Head of the Lab of Immunology, Helmholtz Eye Research Institute in Moscow; Trainee, Laboratory of Immunology, NEI, Bethesda, MD, USA; Chair, Department for Clinical Immunology, Moscow Clinical Research Institute; Executive Secretary-in-Chief of the Editorial Board, Biomedical Science International journal. Honours: Secretary General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; ISPM, Tokyo, Japan; PMC, Washington, DC, USA; ACS, USA; AMEE, Dundee, UK; AHA, USA; EPMA, Brussels.

Immunology & Medicine